Really? Know one can see clearly that leronlimab has absolutely nothing to do with Nader and Kaz insider trading? You don’t think that now that Amarex and Nader with his team are no longer in the picture, that a partner might approach Cytodyn out of interest in leronlimab? I think the new team has made it clear that they are gathering trial data from the past, adding new data as they can to make their case for the potential for leronlimab to attract partners to fund actual fda protocol approval trials.